Small molecule inhibitors of PCSK9-phase II
Ended Project Grant Awarded Last action
- Award ID
- R44HL134462
- Recipient
-
Hingez Therapeutics LLC UEI KKTAV1ACNKA1
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,964,245
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Place of performance
- Rockville, MD 20850, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $145,907 | |
| Amendment | $909,169 | |
| Original award | $909,169 |
Quick answers
Who received award R44HL134462?
R44HL134462 was awarded to Hingez Therapeutics LLC by National Heart Lung and Blood Institute (National Institutes of Health) on July 19, 2016.
How much is award R44HL134462 worth?
$1,964,245 has been obligated on R44HL134462.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award